ARCTURUS THERAPEUTICS HOLDIN (ARCT:NASDAQ)

$13.74 0.87 (6.7599%)

watchlist-icon
search-icon
Profile Icon

Most Recent Average Sentiment Analysis Score (0 to 100): 76

negative-sentiment
Negative [0, 35)
neutral-sentiment
Neutral [35, 65]
positive-sentiment
Positive (65, 100]
Visualize Sentiment Trendline

Analysed ARCTURUS THERAPEUTICS HOLDIN (ARCT:NASDAQ) News Sources

CoreWeave upgraded, Etsy downgraded: Wall Street's top analyst calls

24-09-2026

yahoo.com

external link

4 RNA Therapeutics Stocks Leading the Next Wave of Innovation

28-09-2026

yahoo.com

external link

Arcturus Therapeutics Highlights mRNA Pipeline, CF Data and Vaccine Expansion at Jefferies

05-06-2026

marketbeat.com

external link

Arcturus Therapeutics to Present at the Canaccord Genuity 46th Annual Growth Conference

20-07-2026

yahoo.com

external link

Arcturus Therapeutics Eyes Phase III CF Call, OTC Data as Vaccine Funds Pipeline

12-08-2026

marketbeat.com

external link

Arcturus Therapeutics (ARCT) Just Flashed Golden Cross Signal: Do You Buy?

27-08-2026

yahoo.com

external link

Arcturus Therapeutics to Participate in Upcoming Investor Conferences

31-08-2026

yahoo.com

external link

Arcturus Therapeutics to Present Ornithine Transcarbamylase (OTC) Deficiency Phase 2 Clinical Data and Provide Update on mRNA Liver Therapeutics Platform

18-09-2026

yahoo.com

external link

Arcturus Therapeutics Announces Interim OTC Deficiency Phase 2 Results and Introduces LUNAR 2.0™ Next-Generation mRNA Delivery Platform

23-09-2026

yahoo.com

external link

Arcturus Highlights ARCT-810 Phase II Data, Unveils Next-Gen OTC Therapy Platform

25-09-2026

marketbeat.com

external link

ARCTURUS THERAPEUTICS HOLDIN (ARCT:NASDAQ) Sentiment Trend

0 25 50 75 100 2 91 91 89 91 81 89 77 77 76 24-09-2026 28-09-2026 05-06-2026 20-07-2026 12-08-2026 27-08-2026 31-08-2026 18-09-2026 23-09-2026 25-09-2026 #1 #2 #3 #4 #5 #6 #7 #8 #9 #10 Negative < 35 Neutral 35–65 Positive > 65 View FAQ

ARCTURUS THERAPEUTICS HOLDIN (ARCT:NASDAQ) FAQs

toggle

What is the current price of ARCTURUS THERAPEUTICS HOLDIN (ARCT:NASDAQ)?

The current price of ARCTURUS THERAPEUTICS HOLDIN (ARCT:NASDAQ) is $13.74.


toggle

ARCTURUS THERAPEUTICS HOLDIN (ARCT:NASDAQ) absolute price change since previous trading day?

The absolute price change of ARCTURUS THERAPEUTICS HOLDIN (ARCT:NASDAQ) since the previous trading day is $0.87.


toggle

ARCTURUS THERAPEUTICS HOLDIN (ARCT:NASDAQ) percentage price change since previous trading day?

The percentage price change of ARCTURUS THERAPEUTICS HOLDIN (ARCT:NASDAQ) since the previous trading day is 6.7599%.


toggle

What is the most recent average sentiment score for ARCTURUS THERAPEUTICS HOLDIN (ARCT:NASDAQ)?

The most recent average sentiment score for ARCTURUS THERAPEUTICS HOLDIN (ARCT:NASDAQ) is 76 out of 100.


toggle

What is the most recent average sentiment for ARCTURUS THERAPEUTICS HOLDIN (ARCT:NASDAQ)?

The most recent sentiment for ARCTURUS THERAPEUTICS HOLDIN (ARCT:NASDAQ) is .


SEC-8K** Filing Available For ARCTURUS THERAPEUTICS HOLDIN (ARCT:NASDAQ)

** material developments that could impact a company's financial condition or stock price.

Similar Securities People Also Ask

ARQT (Arcutis Biotherapeutics Inc)
ARCB (Arcbest Corp)
OTLC (Oncotelic Therapeutics Inc)

Author: MattELab

X Icon

GitHub Icon

MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.